Farmak JSC added Nalbuk, a drug for treatment of pain syndrome, to its product portfolio. The new drug is manufactured in the form of solution for injection in 1 or 2 ml ampoule No. 5 or 1 ml syringe No. 5.
Nalbuk is developed on the basis of the active substance nalbuphine. The product is used for treatment of moderate to severe pain. In addition, Nalbuk is recommended for use as a supplementary analgesic drug, to relieve pain during pre- and postoperative period, and for childbirth anesthesia.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...